Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Thank you for standing by and welcome to Heron Therapeutics ...

These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.

Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

We intend to achieve our goals with a high-performing team committed to execute, focus and innovate to drive our continued growth and long-term transformation ... To report SUSPECTED ADVERSE REACTIONS ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq ... Voyager is committed to maintaining a strong balance ...

The job cuts are part of a business restructuring to reduce costs, 23andMe says. Along with layoffs, the company is ...

Axsome Therapeutics surpassed revenue expectations in Q3, driven by strong sales from its key products.

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

The Clark County Council is revisiting a request from ZP#5 LLC, a company controlled by Washougal Pit mine owner Judith ...

This was partly offset by a 1% rise in the company’s revenue from $46 billion to $47 billion over the same period; and a 4.1% ...

As per Deloitte, inflation in the Eurozone slightly rebounded in October but was still quite low. The consumer price index ...

Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...